openPR Logo
Press release

Corticosteroids Marketย is anticipated to generate an estimated revenue of USD 8.53 billion by 2032 | Latest Reports by Polaris Market Research

06-17-2024 01:07 PM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Corticosteroids Market

Corticosteroids Market

๐‘ฎ๐’๐’๐’ƒ๐’‚๐’ ๐‘ช๐’๐’“๐’•๐’Š๐’„๐’๐’”๐’•๐’†๐’“๐’๐’Š๐’…๐’” ๐‘ด๐’‚๐’“๐’Œ๐’†๐’• ๐’”๐’Š๐’›๐’† ๐’‚๐’๐’… ๐’”๐’‰๐’‚๐’“๐’† ๐’Š๐’” ๐’„๐’–๐’“๐’“๐’†๐’๐’•๐’๐’š ๐’—๐’‚๐’๐’–๐’†๐’… ๐’‚๐’• ๐‘ผ๐‘บ๐‘ซ 5.96 ๐’ƒ๐’Š๐’๐’๐’Š๐’๐’ ๐’Š๐’ 2024 ๐’‚๐’๐’… ๐’Š๐’” ๐’‚๐’๐’•๐’Š๐’„๐’Š๐’‘๐’‚๐’•๐’†๐’… ๐’•๐’ ๐’ˆ๐’†๐’๐’†๐’“๐’‚๐’•๐’† ๐’‚๐’ ๐’†๐’”๐’•๐’Š๐’Ž๐’‚๐’•๐’†๐’… ๐’“๐’†๐’—๐’†๐’๐’–๐’† ๐’๐’‡ ๐‘ผ๐‘บ๐‘ซ 8.53 ๐’ƒ๐’Š๐’๐’๐’Š๐’๐’ ๐’ƒ๐’š 2032, ๐’‚๐’„๐’„๐’๐’“๐’…๐’Š๐’๐’ˆ ๐’•๐’ ๐’•๐’‰๐’† ๐’๐’‚๐’•๐’†๐’”๐’• ๐’”๐’•๐’–๐’…๐’š ๐’ƒ๐’š ๐‘ท๐’๐’๐’‚๐’“๐’Š๐’” ๐‘ด๐’‚๐’“๐’Œ๐’†๐’• ๐‘น๐’†๐’”๐’†๐’‚๐’“๐’„๐’‰. ๐‘ฉ๐’†๐’”๐’Š๐’…๐’†๐’”, ๐’•๐’‰๐’† ๐’“๐’†๐’‘๐’๐’“๐’• ๐’๐’๐’•๐’†๐’” ๐’•๐’‰๐’‚๐’• ๐’•๐’‰๐’† ๐’Ž๐’‚๐’“๐’Œ๐’†๐’• ๐’†๐’™๐’‰๐’Š๐’ƒ๐’Š๐’•๐’” ๐’‚ ๐’“๐’๐’ƒ๐’–๐’”๐’• 4.6% ๐‘ช๐’๐’Ž๐’‘๐’๐’–๐’๐’… ๐‘จ๐’๐’๐’–๐’‚๐’ ๐‘ฎ๐’“๐’๐’˜๐’•๐’‰ ๐‘น๐’‚๐’•๐’† (๐‘ช๐‘จ๐‘ฎ๐‘น) ๐’๐’—๐’†๐’“ ๐’•๐’‰๐’† ๐’‡๐’๐’“๐’†๐’„๐’‚๐’”๐’•๐’†๐’… ๐’•๐’Š๐’Ž๐’†๐’‡๐’“๐’‚๐’Ž๐’†, 2024 - 2032

The corticosteroids market is a significant segment within the pharmaceutical industry, focusing on the production and distribution of corticosteroid drugs. These drugs are synthetic versions of hormones produced by the adrenal cortex and are used to treat a wide range of medical conditions due to their anti-inflammatory and immunosuppressive properties. They are commonly prescribed for conditions such as asthma, arthritis, lupus, and skin disorders, among others.

๐‘ฎ๐’‚๐’Š๐’ ๐’†๐’™๐’‘๐’†๐’“๐’• ๐’Š๐’๐’”๐’Š๐’ˆ๐’‰๐’•๐’” ๐’‚๐’๐’… ๐’”๐’–๐’‘๐’†๐’“๐’„๐’‰๐’‚๐’“๐’ˆ๐’† ๐’š๐’๐’–๐’“ ๐’ˆ๐’“๐’๐’˜๐’•๐’‰ ๐’”๐’•๐’“๐’‚๐’•๐’†๐’ˆ๐’Š๐’†๐’”. ๐‘น๐’†๐’’๐’–๐’†๐’”๐’• ๐’๐’–๐’“ ๐’Ž๐’‚๐’“๐’Œ๐’†๐’• ๐’๐’—๐’†๐’“๐’—๐’Š๐’†๐’˜ ๐’”๐’‚๐’Ž๐’‘๐’๐’† ๐’๐’๐’˜: https://www.polarismarketresearch.com/industry-analysis/corticosteroids-market/request-for-sample
Market Size and Growth

The global corticosteroids market has been experiencing steady growth, driven by increasing incidences of chronic diseases, rising awareness of corticosteroid treatments, and advancements in drug formulations. As of the latest reports, the market is valued at several billion dollars, with expectations for continued growth over the next decade.

๐Œ๐š๐ฃ๐จ๐ซ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ:

AbbVie Inc.
Astellas Pharma Inc.
AstraZeneca plc
Bausch Health Companies Inc.
Bayer AG
Cipla Limited
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
Johnson & Johnson
Lupin Limited
Merck & Co., Inc.
Novartis International AG
Pfizer Inc.
Sanofi S.A.

๐‘ฌ๐’™๐’‘๐’๐’๐’“๐’† ๐‘ฐ๐’-๐‘ซ๐’†๐’‘๐’•๐’‰ ๐‘ด๐’‚๐’“๐’Œ๐’†๐’• ๐‘จ๐’๐’‚๐’๐’š๐’”๐’Š๐’”: ๐‘ท๐’–๐’“๐’„๐’‰๐’‚๐’”๐’† ๐‘ต๐’๐’˜ ๐’•๐’ ๐‘จ๐’„๐’„๐’†๐’”๐’” ๐‘บ๐’†๐’ˆ๐’Ž๐’†๐’๐’•-๐’”๐’‘๐’†๐’„๐’Š๐’‡๐’Š๐’„ ๐‘ซ๐’†๐’•๐’‚๐’Š๐’๐’”, ๐‘ผ๐’๐’„๐’๐’—๐’†๐’“ ๐‘ช๐’“๐’–๐’„๐’Š๐’‚๐’ ๐‘ป๐’“๐’†๐’๐’…๐’”, ๐‘ซ๐’“๐’Š๐’—๐’†๐’“๐’”, ๐’‚๐’๐’… ๐‘ช๐’‰๐’‚๐’๐’๐’†๐’๐’ˆ๐’†๐’”: https://www.polarismarketresearch.com/buy/3254/2

๐‘๐ž๐œ๐ž๐ง๐ญ ๐ƒ๐ž๐ฏ๐ž๐ฅ๐จ๐ฉ๐ฆ๐ž๐ง๐ญ๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐‚๐จ๐ซ๐ญ๐ข๐œ๐จ๐ฌ๐ญ๐ž๐ซ๐จ๐ข๐๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

The corticosteroids market has seen notable developments recently, driven by advancements in pharmaceutical research, regulatory changes, and market dynamics. Here's a detailed overview of the latest trends and developments:

๐ˆ๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง๐ฌ ๐ข๐ง ๐ƒ๐ซ๐ฎ๐  ๐ƒ๐ž๐ฅ๐ข๐ฏ๐ž๐ซ๐ฒ ๐’๐ฒ๐ฌ๐ญ๐ž๐ฆ๐ฌ:
Pharmaceutical companies are increasingly focusing on improving the delivery mechanisms of corticosteroids. Innovations such as inhalers, nasal sprays, topical formulations, and sustained-release injectables have enhanced the efficacy and patient compliance. The development of nanotechnology-based delivery systems is particularly noteworthy, as it allows for targeted drug delivery and reduced side effects.

๐ˆ๐ง๐ญ๐ซ๐จ๐๐ฎ๐œ๐ญ๐ข๐จ๐ง ๐จ๐Ÿ ๐๐ข๐จ๐ฌ๐ข๐ฆ๐ข๐ฅ๐š๐ซ ๐‚๐จ๐ซ๐ญ๐ข๐œ๐จ๐ฌ๐ญ๐ž๐ซ๐จ๐ข๐๐ฌ:
The introduction of biosimilar corticosteroids has been a significant development. These biosimilars offer similar therapeutic benefits to their branded counterparts but at a reduced cost, thereby increasing accessibility for patients. Regulatory bodies like the FDA and EMA have approved several biosimilar corticosteroids, which are expected to drive market growth.

๐„๐ฑ๐ฉ๐š๐ง๐๐ž๐ ๐ˆ๐ง๐๐ข๐œ๐š๐ญ๐ข๐จ๐ง๐ฌ ๐š๐ง๐ ๐€๐ฉ๐ฉ๐ซ๐จ๐ฏ๐š๐ฅ๐ฌ:
Recent approvals for corticosteroids in treating a broader range of conditions have expanded the market. Conditions such as chronic obstructive pulmonary disease (COPD), certain cancers, and autoimmune diseases are now increasingly being treated with corticosteroids. This has broadened the application of these drugs beyond their traditional use in inflammatory and allergic conditions.

๐‚๐จ๐ซ๐ญ๐ข๐œ๐จ๐ฌ๐ญ๐ž๐ซ๐จ๐ข๐๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ

In 2023, the glucocorticoids segment accounted for significant market share owing to versatility, management of chronic diseases, and therapeutic advancements.

In 2023, the topical segment accounted for significant market share owing to reduced systemic absorption, localized treatment, and compatibility with other therapies.

In 2023, the skin allergies segment held significant revenue share owing to anti-inflammatory properties, quick symptomatic relief, and wide range of applications.

In 2023, North America region dominated the global market due to established players, regulatory environment, ongoing technological advancements, and research and development.

The market is highly competitive owing to the existence of market players with a global presence, including AbbVie Inc., AstraZeneca plc, Bayer AG, Cipla Limited, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, and Sanofi S.A. among others.

๐‘จ๐’„๐’„๐’†๐’”๐’” ๐’•๐’‰๐’† ๐‘ญ๐’–๐’๐’ ๐‘น๐’†๐’‘๐’๐’“๐’•, ๐’‰๐’†๐’“๐’†: https://www.polarismarketresearch.com/industry-analysis/corticosteroids-market

Polarisย Market Research has segmented the Corticosteroids market report based on type, route of administration, application, and region:

Corticosteroids, Type Outlook (Revenueย -ย USD Billion, 2019 - 2032)

Mineralocorticoids
Glucocorticoids

Corticosteroids, Route of Administration Outlook (Revenueย -ย USD Billion, 2019 - 2032)

Inhaled
Topical
Injectable
Oral

Corticosteroids, Application Outlook (Revenueย -ย USD Billion, 2019 - 2032)

Skin Allergies
Gastroenterology
Endocrinology
Acute Respiratory Diseases
Rheumatology Indications
Others

Corticosteroids, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America
S.
Canada
Europe
France
Germany
UK
Italy
Netherlands
Spain
Russia
Asia Pacific
Japan
China
India
Malaysia
Indonesia
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa

๐Œ๐จ๐ซ๐ž ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐›๐ฒ ๐๐จ๐ฅ๐š๐ซ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

๐„๐๐“ ๐๐ž๐ฏ๐ข๐œ๐ž๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ: https://www.polarismarketresearch.com/industry-analysis/ent-devices-market

๐๐ก๐š๐ซ๐ฆ๐š๐œ๐จ๐ ๐ž๐ง๐จ๐ฆ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.polarismarketresearch.com/industry-analysis/pharmacogenomics-market

๐€๐ง๐ญ๐ข-๐Ž๐›๐ž๐ฌ๐ข๐ญ๐ฒ ๐Œ๐ž๐๐ข๐œ๐š๐ญ๐ข๐จ๐ง ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.polarismarketresearch.com/industry-analysis/anti-obesity-medication-market

๐–๐ž๐š๐ซ๐š๐›๐ฅ๐ž ๐ˆ๐ง๐ฃ๐ž๐œ๐ญ๐จ๐ซ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.polarismarketresearch.com/industry-analysis/wearable-injectors-market

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐ˆ๐ง๐Ÿ๐จ:
Polaris Market Research
30 Wall Street, 8th Floor,
New York City, NY 10005,
United States
Phone:+1-929 297-9727
Email: sales@polarismarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Corticosteroids Marketย is anticipated to generate an estimated revenue of USD 8.53 billion by 2032 | Latest Reports by Polaris Market Research here

News-ID: 3541333 • Views: โ€ฆ

More Releases from Polaris Market Research & Consulting

Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of 5.2%
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of โ€ฆ
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors. Market at a Glance In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. Itโ€ฆ
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 Billion by 2034, Growing at a CAGR of 7.5%
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 โ€ฆ
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 3.82 billion in 2024 and is expected toโ€ฆ
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expanding at a CAGR of 6.8%
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin โ€ฆ
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billionโ€ฆ
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2034, Growing at a CAGR of 7.44%
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 โ€ฆ
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 31.67 billion in 2024 and is expected to reachโ€ฆ

All 5 Releases


More Releases for Corticosteroids

Corticosteroids Market Growth Competitive Dynamics and New Frontiers
The corticosteroids market has shown remarkable progress, underscoring its significance in treating a broad spectrum of conditions. With a global valuation of USD 4.71 billion in 2023, the market is set for robust growth, reaching an estimated size of USD 6.91 billion by 2033. This expansion corresponds to a compound annual growth rate (CAGR) of 4.2% during the forecast period (2023-2033). Get All the Details in Our Solution - Download Brochureโ€ฆ
Topical Corticosteroids Market: A Comprehensive Overview
Introduction Topical corticosteroids are a class of medications widely used in dermatology to manage various inflammatory skin conditions. These drugs are primarily applied directly to the skin to reduce inflammation, redness, and itching caused by conditions like eczema, psoriasis, dermatitis, and other allergic reactions. The market for topical corticosteroids has grown significantly over the years, driven by increasing awareness of skin conditions, advancements in drug formulations, and the rising prevalence ofโ€ฆ
Corticosteroids Market to See Huge Growth | Pfizer, Watson, Sandoz
Global Corticosteroids market size, trend, and forecast to 2030 are assessed in USD Analytics Research's most recent analysis. A valuable resource document for managers, analysts, industry experts, and other key personnel, the Corticosteroids market study includes substantial research data and proofs to help them understand market trends, growth drivers, opportunities, upcoming challenges, and competitors. The study can be easily accessed and self-analyzed. Key Players in This Report Include: Pfizer Inc. (Unitedโ€ฆ
Intranasal Corticosteroids Market 2021 | Detailed Report
ReportsnReports publishes the report titled Intranasal Corticosteroids that presents a 360-degree overview of the market under one roof. The report is developed with the meticulous efforts of an enthusiastic and experienced team of experts, analyts, and researchers that makes the report a valuable asset for stakeholders to make robust decisions. This report also provides an in-depth overview of product type, specification, technology, and production analysis considering vital factors like cost,โ€ฆ
Global Corticosteroids Therapy Market | Global Corticosteroids Therapy Industry โ€ฆ
The corticosteroids therapy market comprises of sales of artificial corticosteroid drugs utilized to treat a wide variety of syndromes, including asthma, arthritis, skin conditions, and autoimmune diseases and lowers inflammation in the body. Corticosteroids and their biologically active synthetic derivatives vary in their metabolic (glucocorticoid) and electrolyte-regulating (mineralocorticoid) activities. These agents are active at physiological doses for additional therapy when endogenous manufacture is impaired. The market involves of revenue createdโ€ฆ
Corticosteroids Market Growth, Trends, Industry Analysis and Forecast - 2025
The global corticosteroids market is estimated to grow at a CAGR of nearly 4.8% during the forecast period. Rising demand for topical and inhaled corticosteroids is primarily encouraging the growth of the market. Increasing prevalence of skin allergies and acute respiratory disorders has significantly increased the adoption of topical and inhaled corticosteroids. In 2018, the number of children under age 18 years with reported skin allergies in the US wasโ€ฆ